Staff Training for a Retatrutide Research Program: What Your Team Needs to Know Before You Enroll the First Patient

A retatrutide research program is only as compliant as the team running it. The IRB holds the Principal Investigator responsible for the conduct of all study personnel — which means that a protocol deviation caused by an untrained staff member is the physician's problem. Getting your team trained before you enroll the first patient is not optional. Here is what that training needs to cover.

Every staff member who touches the research program needs training. This includes:

• Physicians and nurse practitioners who are administering the compound or conducting monitoring visits
• Medical assistants and nurses who are preparing injections, taking vital signs, or documenting adverse events
• Front desk and scheduling staff who are scheduling research visits and handling patient inquiries about the program
• Billing staff if any billing is associated with the research visits (though billing for investigational compound administration is a separate compliance issue that requires careful review)

The depth of training varies by role, but everyone who interacts with research subjects needs to understand the basics.

1. Human Subjects Research Fundamentals

Every staff member involved in the research should complete the CITI Program (Collaborative Institutional Training Initiative) training in human subjects research. The CITI Program is the standard training platform used by IRBs across the country. It covers the history of research ethics, the Belmont Report principles, the federal regulations governing human subjects research, and the specific obligations of research personnel.

CITI training is online, self-paced, and typically takes 4–8 hours to complete. Most IRBs require CITI certification for all study personnel listed on the protocol. Document completion dates and keep certificates in your research files.

2. The Specific Protocol

General human subjects training is not sufficient. Every staff member needs to be trained on your specific protocol — the inclusion and exclusion criteria, the dosing schedule, the monitoring requirements, the adverse event reporting procedures, and the consent process.

This training should be conducted by the Principal Investigator or a designated research coordinator. It should be documented — a training log with the date, the topics covered, and the signature of each staff member trained.

3. Informed Consent Process

The consent process is one of the most legally sensitive aspects of a research program. Staff members who are involved in the consent process — whether they are conducting the consent discussion or witnessing the consent signature — need to understand:

• What the consent document says and why each element is required
• That consent must be voluntary — no pressure, no incentives that could be construed as coercive
• That the patient must have adequate time to review the document and ask questions
• That consent can be withdrawn at any time without penalty
• How to document the consent process in the research record

4. Adverse Event Recognition and Reporting

Every staff member who has patient contact needs to know what an adverse event is, how to recognize one, and what to do when they encounter one. This means:

• Understanding the definition of an adverse event in the research context (broader than the clinical definition)
• Knowing who to notify when an adverse event occurs
• Understanding the difference between a non-serious adverse event and a serious adverse event
• Knowing the reporting timeline for serious adverse events

A staff member who encounters a patient reporting a serious adverse event and does not know what to do — or who documents it informally without triggering the reporting process — creates significant compliance exposure.

5. Cold Chain Handling

Staff members who handle retatrutide — receiving shipments, storing the compound, preparing injections — need training on cold chain requirements. This includes:

• The required storage temperature range
• How to check and document storage temperatures
• What to do if a temperature excursion occurs
• How to document receipt of shipments and verify cold chain integrity upon arrival
• Proper injection preparation technique

6. Research Records Management

Staff members who document research activities need to understand the difference between clinical records and research records, and the requirements for each. Research records must be:

• Complete — every required data point documented
• Accurate — no corrections without a dated, initialed notation
• Retained for the required period (minimum three years after study completion)
• Accessible for IRB audit

Training is not a one-time event. When your protocol is amended, when new adverse event data becomes available, or when a protocol deviation occurs, your team needs to be updated. Document all ongoing training the same way you document initial training.

Maintain a training file for your research program that includes:

• CITI Program completion certificates for all study personnel
• Protocol-specific training logs with dates, topics, and signatures
• Any ongoing training records

This file is one of the first things an IRB auditor will ask for. Having it organized and complete demonstrates that your program takes compliance seriously.